Elder Pharmaceuticals today said its shareholders have approved a final dividend of 30 per cent for the financial year ended March 31,2011. Shareholders at the company's annual general meeting (AGM) held today have approved a final dividend of Rs 3 per share of Rs 10 face value (30 per cent) for the fiscal ended March 31,2011,Elder Pharma said in a statement. The company's shareholders have also approved the appointment of Alok Saxena as Joint Managing Director (JMD) of the company for a period of five years,effective from August 12,2011,it added. Prior to his appointment as JMD,Alok Saxena was working as Director,International Marketing,in the company,it said. The shareholders also approved the re-appointment of Joginder Singh Juneja,Eduardo Richter and Urvashi Saxena as directors of the company. The Mumbai-based drug firm has a presence in niche therapeutic segments like women's healthcare,wound care,nutraceuticals,vitamin supplements,cardiology,diabetes,dermatology,antibiotics and neurology. The company has six manufacturing plants in India,located in Maharashtra,Uttarakhand and Himachal Pradesh. Shares of Elder Pharma were being quoted at Rs 369.30 on the Bombay Stock Exchange in late afternoon trade today,down 1.66 per cent from their previous close. Company INFO More on Elder Pharma Stocks More on Elder Pharma
